INVIVO THERAPEUTICS HOLDINGS CORP. - FORM S-1/A - EX-23.1 - CONSENT OF WOLF & COMPANY, P.C. - May 19, 2011

Attached files

file filename
S-1/A - AMENDMENT NO.1 TO FORM S-1 - INVIVO THERAPEUTICS HOLDINGS CORP.ds1a.htm
EX-2.3 - CERTIFICATE OF MERGER - INVIVO THERAPEUTICS HOLDINGS CORP.dex23.htm
EX-5.1 - OPINION OF BRL LAW GROUP LLC - INVIVO THERAPEUTICS HOLDINGS CORP.dex51.htm
EX-2.2 - AGREEMENT AND PLAN OF MERGER - INVIVO THERAPEUTICS HOLDINGS CORP.dex22.htm
EX-10.5 - SPLIT-OFF AGREEMENT - INVIVO THERAPEUTICS HOLDINGS CORP.dex105.htm
EX-10.6 - GENERAL RELEASE AGREEMENT - INVIVO THERAPEUTICS HOLDINGS CORP.dex106.htm
EX-10.1 - SECURITIES PURCHASE AGREEMENT - INVIVO THERAPEUTICS HOLDINGS CORP.dex101.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the use in this Amendment No. 1 to the Registration Statement on Form S-1 of InVivo Therapeutics Holdings Corporation of our report dated March 24, 2011, relating to our audits of the financial statements of InVivo Therapeutics Holdings Corporation, appearing in the Prospectus, which is part of this Registration Statement.

We also consent to the reference to our firm under the caption "Experts" in such Prospectus.

 

/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
May 19, 2011

Stock widget

Investing forum

INVIVO THERAPEUTICS HOLDINGS CORP. Reports